These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26316104)

  • 1. Variations in inflammatory genes as molecular markers for prediction of inflammatory bowel disease occurrence.
    Stankovic B; Dragasevic S; Popovic D; Zukic B; Kotur N; Sokic-Milutinovic A; Alempijevic T; Lukic S; Milosavljevic T; Nikcevic G; Pavlovic S
    J Dig Dis; 2015 Dec; 16(12):723-33. PubMed ID: 26316104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
    Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
    J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.
    Tolentino YF; Elia PP; Fogaça HS; Carneiro AJ; Zaltman C; Moura-Neto R; Luiz RR; Carvalho Mda G; de Souza HS
    Dig Dis Sci; 2016 Sep; 61(9):2636-47. PubMed ID: 27107867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
    Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
    World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.
    Rigoli L; Romano C; Caruso RA; Lo Presti MA; Di Bella C; Procopio V; Lo Giudice G; Amorini M; Costantino G; Sergi MD; Cuppari C; Calabro GE; Gallizzi R; Salpietro CD; Fries W
    World J Gastroenterol; 2008 Jul; 14(28):4454-61. PubMed ID: 18680223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease.
    Boukercha A; Mesbah-Amroun H; Bouzidi A; Saoula H; Nakkemouche M; Roy M; Hugot JP; Touil-Boukoffa C
    World J Gastroenterol; 2015 Jul; 21(25):7786-94. PubMed ID: 26167078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.
    Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR
    J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toll-like receptor gene polymorphisms and susceptibility to inflammatory bowel disease in Chinese Han and Caucasian populations].
    Shen XY; Shi RH; Wang Y; Zhang HJ; Zhou XQ; Shen FC; Li KB
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1416-20. PubMed ID: 20646633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
    Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
    World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis.
    Tountas NA; Casini-Raggi V; Yang H; Di Giovine FS; Vecchi M; Kam L; Melani L; Pizarro TT; Rotter JI; Cominelli F
    Gastroenterology; 1999 Oct; 117(4):806-13. PubMed ID: 10500062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
    Franchimont D; Vermeire S; El Housni H; Pierik M; Van Steen K; Gustot T; Quertinmont E; Abramowicz M; Van Gossum A; Devière J; Rutgeerts P
    Gut; 2004 Jul; 53(7):987-92. PubMed ID: 15194649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis.
    Meena NK; Verma R; Verma N; Ahuja V; Paul J
    J Clin Gastroenterol; 2013 Oct; 47(9):773-80. PubMed ID: 23470644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
    Stallhofer J; Friedrich M; Konrad-Zerna A; Wetzke M; Lohse P; Glas J; Tillack-Schreiber C; Schnitzler F; Beigel F; Brand S
    Inflamm Bowel Dis; 2015 Oct; 21(10):2327-40. PubMed ID: 26263469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in Saudi patients with Crohn's Disease.
    Azzam N; Nounou H; Alharbi O; Aljebreen A; Shalaby M
    Int J Mol Sci; 2012; 13(4):4268-4280. PubMed ID: 22605977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype.
    Glas J; Török HP; Tonenchi L; Kapser J; Schiemann U; Müller-Myhsok B; Folwaczny M; Folwaczny C
    Inflamm Bowel Dis; 2005 Dec; 11(12):1031-7. PubMed ID: 16306764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease.
    Lin Z; Nelson L; Franke A; Poritz L; Li TY; Wu R; Wang Y; MacNeill C; Thomas NJ; Schreiber S; Koltun WA
    J Crohns Colitis; 2010 Jun; 4(2):132-8. PubMed ID: 21122496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
    Vijgen L; Van Gysel M; Rector A; Thoelen I; Esters N; Ceelen T; Vangoidsenhoven E; Vermeire S; Rutgeerts P; Van Ranst M
    Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
    Figueroa C; Peralta A; Herrera L; Castro P; Gutiérrez A; Valenzuela J; Aguillón JC; Quera R; Hermoso MA
    Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.